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Editorial on the Research Topic
Advances in Analytical Methods for Drugs of Abuse Testing
This collection focuses on innovative approaches and analytical advancement in drugs of abuse
testing and monitoring. Substance abuse negatively impacts all facets of society. Drug testing
programs have been developed in many jurisdictions to service law enforcement agencies for drug
intelligence, criminal justice systems for prosecution of drug-related crimes, and the health industry
for harm minimization.
One significant challenge in drugs of abuse testing is the continuous emergence of new
psychoactive substances (NPS) in the illicit drug market. Routine methods of analysis are no longer
effective in screening NPS due to the lack of structural information and commercial reference
materials which are needed for performing targeted analysis of these NPS. Scientists are developing
non-targeted approaches to overcome this difficulty. In this regard, the use of high-resolution
mass spectrometry (HRMS) operated in data dependent acquisition (DDA) mode or more often
data independent acquisition (DIA) mode has drawn a wide interest among forensic toxicologists
and chemists to advance the non-targeted approach for NPS detection (Pasin et al., 2017). In this
topic collection, Klingberg et al. investigated the mass fragmentation during the collision-induced
dissociation process of a series of synthetic opioids including fentanyl derivatives, AH series
opioids, U series opioids, W series opioids and MT-45, and identified a number of common
fragments that can potentially be used as markers to indicate the presence of a particular synthetic
opioid class of compounds within a sample.
Another significant advancement in the area of non-targeted analysis is the development
of activity-based assays such as the one for the detection of synthetic cannabinoid receptor
agonists (SCRAs) based on interactions of the compounds with CB1 and CB2 receptors
(Cannaert et al., 2017). Availability of such a method can potentially be used to screen biofluids
for the presence of SCRAs without the chemical structural information. The assay can also be used
to evaluate the “intrinsic potency” of SCRA formulations, as demonstrated by Antonides et al. who
synthesized enantiospecifically 4 indazole-3-carboxamide-type SCRA for aiding their detection in
seized drug samples.
Steuer et al. reviewed the recent development of metabolomics approaches for drugs of abuse
testing based on the monitoring of changes in small endogenous molecules in response to drugs
of abuse consumption and to specimen manipulation. Based on the limited number of studies
reported in the literature, the authors conclude that metabolomic approaches possess potential
for detection of biomarkers indicating drug consumption. More studies, including more sensitive
targeted analyses, multi-variant statistical models or deep-learning approaches are needed to fully
explore the potential of omics science in drugs of abuse testing, especially in testing consumption
of unknown NPS.
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Adding to the challenge of detecting the use of a large
number of NPS available in the illicit drug market is the
limited understanding of their biotransformation following
consumption. Many NPS such as SCRAs undergo extensive
metabolic transformation in the body and drugmonitoring needs
to target not only the parent drugs but also their metabolites.
Studying the metabolism of these compounds is also important
to better understand the toxicity of NPS asmanyNPSmetabolites
are also pharmacologically active and contribute to the overall
toxicity of the parent drugs. Xu et al. studied the metabolism of
AMB-FUBINACA, another indazole-3-carboxamide-type SCRA,
using both human liver microsomes and zebra fish systems,
and discovered a number of unique metabolites to be used
as potential poisoning markers for drug monitoring purpose.
Diao and Huestis reviewed the advantages and disadvantages
of multiple metabolic approaches for investigating SCRA
metabolism, including the human hepatocyte incubation model,
human liver microsomes incubation, in silico prediction, rat
in vivo, zebrafish, and fungus Cunninghamella elegans models
and recommended the use of the human hepatocyte model
when possible.
Another important aspect of the collection covers the
development of sensitive analytical test methods for the detection
of drugs of abuse in a variety of biological matrices. Chen
et al. reported the development and validation of a simple,
rapid, and sensitive LC-MS/MS method for chiral analysis
of selegiline and its metabolites desmethylselegiline, R/S-
methamphetamine, and R/S-amphetamine in dried urine spots.
Busardò et al. developed a comprehensive LC-MS/MS method
for quantifying fentanyl and 22 analogs and metabolites in whole
blood, urine, and hair.
In summary, this collection covers Research Topics
representative of a number of important research focuses
in the area of drugs of abuse testing. Speedy, sensitive and
accurate detection of drugs of abuse, including NPS, is part of
the crucial steps in the fight against substance misuse and its
associated crimes and harms.
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